Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4053 vs pranlukast in seasonal allergic rhinitis (Phase 2a, Japan)
jRCT2080222655Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ONO-4053 in seasonal allergic rhinitis (SAR) and Japanese cedar pollinosis (2 arms), sponsored by Ono Pharmaceutical.
02
Drugs
ONO-4053
03
Conditions
seasonal allergic rhinitis (SAR)Japanese cedar pollinosis
Beyond the preview
Go deeper on jRCT2080222655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222655.